Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy Study of Botulinum Toxin Type A to Treat Lower Urinary Symptoms Due to Benign Prostatic Hyperplasia

NCT00284518 is registered in ClinicalTrials.gov with Allergan as lead sponsor.

NCT NCT00284518
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00284518 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy Study of Botulinum Toxin Type A to Treat Lower Urinary Symptoms Due to Benign Prostatic Hyperplasia
Lead sponsor
Allergan
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2005
Completion date
May 31, 2010
Enrollment
380 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

benign prostatic hyperplasia